Latest News
Microsoft's AI Investment Strategy Faces Critical Earnings Scrutiny
Microsoft shares declined 1.3% ahead of its April 29 earnings, with investors divided over whether massive AI investments will deliver returns. The company faces margin pressure as capital spending jumped 66% to $37.5 billion last quarter.
AMD Shares Dip After Rally as Analysts Boost Targets on AI CPU Demand
AMD shares declined 1.4% on Monday, cooling off after a record-breaking rally, while analysts at Bank of America and Stifel increased their price targets, highlighting growing AI infrastructure demand for central processors.
Intel Shares Retreat from 24-Year Peak as AI CPU Strategy Faces Earnings Scrutiny
Intel shares declined 3.5% to $66.08, pulling back from a 24-year high ahead of its April 23 earnings. The report is seen as a key test for whether AI spending is broadening to benefit CPU makers.
Hims & Hers Soars on FDA Catalyst as Omnicell Underperforms
Hims & Hers Health shares surged nearly 9% Monday, extending a strong weekly gain ahead of its May earnings report and a key FDA meeting on peptides. Omnicell reported mixed Q4 results with a net loss.
Broadcom's AI Surge Faces Test as Google Explores Marvell Chip Deal
Broadcom shares declined after reports surfaced that Google is in discussions with Marvell Technology for new AI chips, potentially impacting Broadcom's custom silicon business. Despite this, Broadcom's AI revenue soared 106% last quarter to $8.4 billion.
Gold Retreats as Dollar Strength, Oil Surge Cloud $5,000 Outlook
Gold declined on Monday, pressured by a firmer U.S. dollar and a sharp jump in oil prices. The rally in crude, driven by renewed U.S.-Iran tensions, shifted market focus toward inflation risks, undermining bullion's traditional safe-haven appeal.
Boeing Showcases Chinook Drone Tech as Commercial Recovery Hinges on Q1 Earnings
Boeing is promoting advanced drone and autonomy features for its Chinook helicopter as investors await first-quarter earnings, with the commercial division's recovery and production targets under the microscope.
Lilly Acquires Kelonia in $7B Bet on In-Body CAR-T Cancer Therapy
Eli Lilly will purchase Kelonia Therapeutics in a deal valued at up to $7 billion, gaining an experimental in-body CAR-T therapy for blood cancer. Lilly shares rose 2.5% on the news.
7-Eleven to Shutter 645 Stores, Delays North American IPO Amid Strategic Shift
Seven & i Holdings plans to close 645 7-Eleven stores in North America in fiscal 2026 while opening 205 new locations, reducing its total footprint. The company has postponed its planned North American IPO to fiscal 2027 or beyond.
XRP Holds Steady Near $1.40 Amid Geopolitical Tensions, Solana Integration
XRP traded sideways near $1.40 early Monday, showing resilience as broader markets turned cautious. The token's market capitalization remained around $87 billion with $3 billion in daily volume.
